HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brushia, R. J. Articles by Bielicki, J. K. Search for Related Content PubMed PubMed Citation Articles by Brushia, R. J. Articles by Bielicki, J. K. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 42, 951-958, June 2001
Copyright © 2001 by Lipid Research, Inc.

Baculovirus-mediated expression and purification of human serum paraoxonase 1A

Correspondence to: John K. Bielicki, To whom correspondence should be addressed., jkbielicki{at}lbl.gov (E-mail)

Human paraoxonase 1 (hPON1) is a lipid-associated enzyme transported on HDL. There is considerable interest in hPON1 because of its putative antioxidative/antiatherogenic properties. We have created a recombinant baculovirus (BV) to generate hPON1A in large quantities for structure-function studies and here describe the method for production and isolation of the enzyme. A high level of recombinant hPON1 type A (rPON1A) was produced by Hi-5 insect cells (40 mg/l); a fraction (10 mg/l) was secreted into the cell culture medium, but the majority (30 mg/l) remained associated with the host insect cells. Cell-associated rPON1A was purified by detergent extraction (Tergitol NP-10) followed by three simple chromatography steps (DEAE-Sepharose, Sephacryl S-200, and concanavalin A). The purified enzyme bound to concanavalin A and was converted to a lower molecular mass by endoglycosidase H digestion, suggesting that rPON1A contained high-mannose N-glycan chains. There was a significant decrease in arylesterase activity (>99%) concomitant with enzymatic deglycosylation. rPON1A was dependent on Ca²⁺ for arylesterase activity, exhibiting kinetic parameters similar to native hPON1A (K_m = 3.8 ± 2.1 vs. 3.7 ± 2.0 mM and V_max = 1,305 ± 668 vs. 1,361 ± 591 U/mg protein, rPON1A and hPON1A, respectively). Both rPON1A and hPON1A efficiently inhibited lipoxygenase-mediated peroxidation of phospholipid. In contrast to the arylesterase activity, which was sensitive to endoglycosidase H treatment, enzymatic deglycosylation did not inhibit the antioxidant activity of rPON1A.

In conclusion, our BV-mediated PON1A expression system appears ideally suited for the production of relatively large quantities of rPON1A for structure-function studies. — Brushia, R. J., T. M. Forte, M. N. Oda, B. N. La Du, and J. K. Bielicki. Baculovirus-mediated expression and purification of human serum paraoxonase 1A. J. Lipid Res. 2001. 42: 951;–958.

Supplementary key words: recombinant paraoxonase, HDL, lipid peroxidation, antioxidant, atherogenesis

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Kriska, G. K. Marathe, J. C. Schmidt, T. M. McIntyre, and A. W. Girotti Phospholipase Action of Platelet-activating Factor Acetylhydrolase, but Not Paraoxonase-1, on Long Fatty Acyl Chain Phospholipid Hydroperoxides J. Biol. Chem., January 5, 2007; 282(1): 100 - 108. [Abstract] [Full Text] [PDF]

				D. I. Draganov, J. F. Teiber, A. Speelman, Y. Osawa, R. Sunahara, and B. N. La Du Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities J. Lipid Res., June 1, 2005; 46(6): 1239 - 1247. [Abstract] [Full Text] [PDF]

				X. Zhu, G. Wu, W. Zeng, H. Xue, and B. Chen Cysteine mutants of human apolipoprotein A-I: a study of secondary structural and functional properties J. Lipid Res., June 1, 2005; 46(6): 1303 - 1311. [Abstract] [Full Text] [PDF]

				A. Aharoni, L. Gaidukov, S. Yagur, L. Toker, I. Silman, and D. S. Tawfik Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization PNAS, January 13, 2004; 101(2): 482 - 487. [Abstract] [Full Text] [PDF]

				G. Rossoni, M. Gomaraschi, F. Berti, C. R. Sirtori, G. Franceschini, and L. Calabresi Synthetic High-Density Lipoproteins Exert Cardioprotective Effects in Myocardial Ischemia/Reperfusion Injury J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 79 - 84. [Abstract] [Full Text] [PDF]

				V. G. Cabana, C. A. Reardon, N. Feng, S. Neath, J. Lukens, and G. S. Getz Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response J. Lipid Res., April 1, 2003; 44(4): 780 - 792. [Abstract] [Full Text] [PDF]

				D. Josse, C. Ebel, D. Stroebel, A. Fontaine, F. Borges, A. Echalier, D. Baud, F. Renault, M. le Maire, E. Chabrieres, et al. Oligomeric States of the Detergent-solubilized Human Serum Paraoxonase (PON1) J. Biol. Chem., August 30, 2002; 277(36): 33386 - 33397. [Abstract] [Full Text] [PDF]